首页>
外国专利>
Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid
Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid
展开▼
机译:琥珀酰亚胺的口服剂型-用于预防和治疗草酸引起的结石症
展开▼
页面导航
摘要
著录项
相似文献
摘要
Therapeutic compsn for oral administration comprises 1-2g of succinimide per unit dosage form and prevents and cures urinary lithiasis due to excess oxalic acid in urine. The adult clinical dose is 5-10 g/day for about 6 weeks.
展开▼
机译:口服给药的治疗成分每单位剂型包含1-2g琥珀酰亚胺,可预防和治疗由于尿中草酸过多而引起的尿结石症。成人临床剂量为5-10 g /天,持续约6周。
展开▼